Cargando…
Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
OBJECTIVE: Rap2c is a member of the Ras superfamily that has been implicated in various types of cancers. However, its role in glioma remains elusive. This study aimed to elucidate the role of Rap2c in glioma and its specific molecular mechanism. METHODS: We determined the expression of Rap2c in gli...
Autores principales: | Wang, Xiucun, Wang, Cheng, Xi, Lin, Yu, Zhengquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166057/ https://www.ncbi.nlm.nih.gov/pubmed/32341653 http://dx.doi.org/10.2147/OTT.S247731 |
Ejemplares similares
-
The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022) -
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
por: Sun, Jin-Zhang, et al.
Publicado: (2021) -
Ras-related protein Rap2c promotes the migration and invasion of human osteosarcoma cells
por: Wu, Jinxia, et al.
Publicado: (2021) -
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022) -
KLF11 Expression Predicts Poor Prognosis in Glioma Patients
por: Xi, Zhuo, et al.
Publicado: (2021)